Bioidentical hormone replacement therapy (BHRT) uses hormones that are chemically identical to the ones your body makes (such as estradiol, progesterone, and testosterone). “HRT” is an umbrella term for any hormone therapy – bioidentical or non-bioidentical – and may include FDA-approved products as well as compounded preparations. The right option depends on your goals, medical history, and safety profile; talk with a clinician before starting, and seek care urgently for severe chest pain, shortness of breath, or sudden neurological symptoms.
Key Points
- Definitions matter: BHRT = body-identical molecules (e.g., 17β-estradiol, micronized progesterone). HRT = any hormone therapy (bioidentical or not), including conjugated estrogens (equine estrogen) or certain progestins.
- Forms & sourcing: BHRT can be FDA-approved (e.g., estradiol patches; micronized progesterone capsules) or compounded (custom-mixed) when a suitable commercial option doesn’t fit – each approach has benefits and trade-offs.
- What to expect: Many people notice changes in sleep, hot flashes, mood, and vaginal comfort within days or weeks; body composition, bone, and cardiometabolic markers evolve over months. Results vary.
- Monitoring matters: Responsible BHRT includes intake review, baseline labs as clinically indicated, dose titration, and follow-ups to watch benefits and side effects.
- Risks & side effects: Possible breast tenderness, bloating, headache, skin irritation (topicals), mood shifts; estrogen can raise clot risk in some people (especially oral forms). Seek urgent care for chest pain, shortness of breath, leg swelling, severe headache/vision change, or heavy/irregular bleeding.
- Who it helps / not for: Candidates typically include symptomatic perimenopause/menopause with appropriate screening. Those with certain cancer or clotting histories may need alternatives – decisions are individualized.
- If you’re seeking a BHRT provider in Boston, MA, we offer consults and telehealth options to review your fit and plan.
Understanding HRT and BHRT
HRT (hormone replacement therapy) is a broad term for using hormones – most commonly estrogen and progesterone, and sometimes testosterone – to relieve menopause or hormone-related symptoms and protect long-term health concerns such as bone loss.
BHRT (bioidentical HRT) uses hormones that are chemically identical to the hormones your body makes (for example, 17β-estradiol rather than a different estrogen molecule). Micronized progesterone is bioidentical; some older progestins (different molecules) are not.
You’ll see two sourcing pathways:
FDA-approved products (brand or generic): standardized doses, quality-controlled manufacturing, labeled risks/benefits. Examples include estradiol patches/gels and oral micronized progesterone.
Compounded preparations: custom-formulated by a compounding pharmacy (e.g., a combined estradiol/progesterone cream or a dose form not commercially available). Compounding can match unique dosing needs or sensitivities, but compounded medications aren’t FDA-approved and depend on the pharmacy’s rigorous quality controls.
We use compounded, bioidentical hormones in a variety of forms when individualized dosing is helpful – and we also discuss FDA-approved options. The choice is collaborative and based on your history, goals, and safety profile.
How It Works / What’s Involved
A responsible BHRT/HRT journey looks like this:
- Comprehensive intake: medical history (including breast/gynecologic and clotting history), medications, family history, symptom review, and goals.
- Baseline testing (as indicated): labs may include estradiol/progesterone context, thyroid markers, lipids, glucose/insulin, vitamin D, and others based on symptoms and history. Testing guides a personalized plan – it is not a diagnosis in isolation.
- Selecting route & dose: transdermal estradiol (patch/gel) is often preferred for some patients because it may have a lower clot risk than oral in certain contexts; micronized progesterone supports uterine protection when estrogen is used and the uterus is present. Testosterone use in women is individualized and off-label in many countries, discuss risks/benefits.
- Trial period & titration: start low, reassess symptoms and tolerance in 4–12 weeks; adjust route/dose as needed.
- Ongoing monitoring: periodic follow-ups, safety checks, and labs as clinically appropriate. We watch symptoms, side effects, blood pressure, and relevant labs; regimens change over time.
Is It Right For Me?
People who may benefit include those with bothersome perimenopausal or menopausal symptoms (e.g., hot flashes/night sweats, hair loss, sudden weight gain, sleep disruption, joint pain, genitourinary symptoms, mood and cognitive changes) after individualized risk assessment. BHRT can also be part of a plan addressing bone health and quality of life.
People who may not be candidates – or who need a modified approach – can include those with a history of estrogen-sensitive cancers, unexplained vaginal bleeding, active or past blood clots or clotting disorders, severe liver disease, or uncontrolled cardiovascular risk. Some may still qualify with specialist input and careful route selection (for example, transdermal rather than oral), but decisions are case-by-case.
Realistic expectations: Sleep and vasomotor symptoms may ease within days or weeks; energy, mood, sexual comfort, and cognition often improve over 1–3 months; bone density/metabolic changes take longer. Lifestyle – nutrition, movement, stress, alcohol, and sleep hygiene – still matters and can amplify benefits.
Safety, Side Effects & Monitoring
Common side effects can include breast tenderness, spotting/irregular bleeding (early on), bloating, fluid shifts, headaches, skin irritation (topicals), or mood changes. These often improve with dose/formulation adjustments.
When to contact the clinic: persistent or worsening symptoms, bothersome side effects, or any unexpected bleeding after the first few months of therapy.
Seek urgent care immediately for chest pain, shortness of breath, calf pain/swelling, severe headache or vision changes, one-sided weakness/numbness, or heavy vaginal bleeding. These could indicate serious complications that require prompt evaluation.
We practice responsible BHRT informed by testing, shared decision-making, and routine follow-ups. We offer telehealth options to support convenient check-ins for our Boston community and beyond where permitted.
Next Steps
If you’re comparing BHRT vs HRT and want help deciding what fits your history and goals, our team in Boston, MA can review your options, including bioidentical, compounded forms and FDA-approved therapies, and outline a safe monitoring plan.
Learn more about our approach to BHRT for women
Ready to talk it through? Book a discovery call to see if this is a fit for you.
Sources:
- North American Menopause Society (NAMS). The 2022 Hormone Therapy Position Statement.
- Endocrine Society. Compounded Bioidentical Hormone Therapy Scientific Statement.
- ACOG. Compounded Bioidentical Menopausal Hormone Therapy (Clinical Consensus, 2023).NIH/NCBI. Menopausal Hormone Therapy—risks and benefits overview.
- NIH/NCBI. Menopausal Hormone Therapy—risks and benefits overview.